International Journal of Clinical and Pharmaceutical Innovations

An International Peer Reviewed Open Access Journal

International Journal of Clinical and Pharmaceutical Innovations

An International Peer Reviewed Open Access Journal

ISSN (Print): ---
ISSN (Online): ---

editor@ijcpi.com

Impact: Soon

DEVELOPMENT & EVALUATION OF NAPROXEN LOADED TRANSFEROSOME TO IMPROVE TRANSDERMAL DELIVERY

Pratibha Nirmal*, B. K. Dubey, Anuj Asati, Deepak Basedia, Sunil Kumar Shah
Full Article

Abstract

The present study focuses on the development and evaluation of Naproxen-loaded transferosomes to enhance transdermal drug delivery. Transferosomes were prepared using the thin-film hydration method by varying concentrations of soy lecithin, cholesterol, and Tween 80. The prepared formulations were evaluated for vesicle size, zeta potential, and entrapment efficiency. The vesicle size was found to be in the nanometer range, with the optimized formulation exhibiting the smallest size and highest stability as indicated by a high negative zeta potential. The entrapment efficiency of the formulations was satisfactory, with the optimized formulation showing maximum drug loading due to an optimal lipid composition. The optimized transferosomal formulation was further incorporated into a Carbopol gel base to improve ease of application and patient compliance. The prepared gel formulations were evaluated for viscosity, spreadability, extrudability, and drug content, and showed acceptable physicochemical properties. The in-vitro drug release study of the optimized gel demonstrated a sustained and controlled release pattern over an extended period, in contrast to the rapid release of the conventional formulation. Release kinetics studies revealed that the drug release followed first-order kinetics with a diffusion-controlled mechanism. The overall findings suggest that transferosomes are a promising vesicular carrier system for enhancing the transdermal delivery of Naproxen by improving drug permeation, stability, and therapeutic efficacy while reducing dosing frequency and side effects.

References

  • Alkilani AZ, Nasereddin J, Hamed R, Nimrawi S, Hussein G, Abo-Zour H, Donnelly RF. Beneath the skin: a review of current trends and future prospects of transdermal drug delivery systems. Pharmaceutics, 2022 May 28; 14(6): 1152.
  • Prausnitz MR, Elias PM, Franz TJ, Schmuth M, Tsai JC, Menon GK, Holleran WM, Feingold KR. Skin barrier and transdermal drug delivery. Dermatology, 2012 Jan; 3(18): 2065-73.
  • Simrah, Hafeez A, Usmani SA, Izhar MP. Transfersome, an ultra-deformable lipid-based drug nanocarrier: an updated review with therapeutic applications. Naunyn-Schmiedeberg's Archives of Pharmacology, 2024 Feb; 397(2): 639-73.
  • Jain AK, Kumar F. Transfersomes: Ultradeformable vesicles for transdermal drug delivery. Asian J. Biomater. Res., 2017; 3: 1-3.
  • Stoev SN, Gueorguiev SR, Madzharov VG, Lebanova HV. Naproxen in pain and inflammation–a review. Int J Pharm Phytopharm Res., 2021 Feb; 11(1): 142-8.
  • Malakar, Jadupati, Suma Oomen Sen, Amit Kumar Nayak, and Kalyan Kumar Sen. 2012. Formulation, Optimization and Evaluation of Transferosomal Gel for Transdermal Insulin Delivery. Saudi Pharmaceutical Journal, 20(4): 355–63. 
  • Ghanbarzadeh, Saeed, and Sanam Arami. 2013. Enhanced Transdermal Delivery of Diclofenac Sodium via Conventional Liposomes, Ethosomes, and Transfersomes. BioMed Research International, 2013.
  • Wu, Pey Shiuan et al. 2019. “Preparation and Evaluation of Novel Transfersomes Combined with the Natural Antioxidant Resveratrol.” Molecules, 24(3): 1–12.
  • Qushawy, Mona, Ali Nasr, Mohammed Abd-Alhaseeb, and Shady Swidan. 2018. “Design, Optimization and Characterization of a Transfersomal Gel Using Miconazole Nitrate for the Treatment of Candida Skin Infections.” Pharmaceutics, 10(1).
  • Gupta, Ankit, Geeta Aggarwal, Samita Singla, and Ritika Arora. 2012. “Transfersomes: A Novel Vesicular Carrier for Enhanced Transdermal Delivery of Sertraline: Development, Characterization, and Performance Evaluation.” Scientia Pharmaceutica, 80(4): 1061–80.
  • Hanpramukkun N., Kongmuang S., Chansiri G., The stability of clindamycin phosphate in w/o/w multiple emulsions, Int J Pharm Sci Tec, 2009; 3(2): 1-7.
  • Jivrani Shilpa D, Patel Vijay K, Formulation, Development And Evaluation of Niosomal Drug Delivery System For Clindamycin Phosphate, Pharma Science Monitor, 2014; 5(2): 256-274.
  • Mishra M. and Biswal P., Complexation, Optimization, Formulation development and characterization of Clindamycin phosphate gel using zinc acetate dehydrate, international journals of pharmacy, 2012; 2(3): 472-486.
  • Nimker V, Jamal H, Ghosh P, Jain S, Beotra A. Liposomes: drug delivery system or possible doping agent, Journal of Drug Delivery and Therapeutics, 2017; 7(1): 25-29.

QR

QR Code

Citation

Pratibha Nirmal*1, B. K. Dubey2, Anuj Asati1, Deepak Basedia2, Sunil Kumar Shah2. (2026). Development & Evaluation Of Naproxen Loaded Transferosome To Improve Transdermal Delivery. International Journal of Clinical and Pharmaceutical Innovations, 1(3), 57-61.
DOI: https://doi.org/10.5281/zenodo.20474344

Copyright © Creative Commons Attribution 4.0 (CC BY 4.0)

Keywords

Naproxen Transferosomes Transdermal drug delivery Thin-film hydration method Entrapment efficiency Vesicle size Zeta potential Carbopol gel Sustained release Release kinetics.